TY - STD TI - World Health Organization. Global Polio Eradication Initiative: Polio Eradication and Endgame Strategic Plan (2013–2018). Geneva, 2013; Report No.: ​WHO/POLIO/13.02. ID - ref1 ER - TY - JOUR AU - Thompson, K. M. AU - Duintjer Tebbens, R. J. PY - 2014 DA - 2014// TI - Modeling the dynamics of oral poliovirus vaccine cessation JO - J Infect Dis VL - 210 UR - https://doi.org/10.1093/infdis/jit845 DO - 10.1093/infdis/jit845 ID - Thompson2014 ER - TY - JOUR AU - Duintjer Tebbens, R. J. AU - Thompson, K. M. PY - 2014 DA - 2014// TI - Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation JO - J Infect Dis VL - 210 UR - https://doi.org/10.1093/infdis/jit838 DO - 10.1093/infdis/jit838 ID - Duintjer Tebbens2014 ER - TY - JOUR AU - Duintjer Tebbens, R. J. AU - Pallansch, M. A. AU - Wassilak, S. G. F. AU - Cochi, S. L. AU - Thompson, K. M. PY - 2015 DA - 2015// TI - Combinations of quality and frequency of immunization activities to stop and prevent poliovirus transmission in the high-risk area of northwest Nigeria JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0130123 DO - 10.1371/journal.pone.0130123 ID - Duintjer Tebbens2015 ER - TY - JOUR AU - Kalkowska, D. A. AU - Duintjer Tebbens, R. J. AU - Thompson, K. M. PY - 2014 DA - 2014// TI - Modeling strategies to increase population immunity and prevent poliovirus transmission in two high-risk areas in northern India JO - J Infect Dis VL - 210 UR - https://doi.org/10.1093/infdis/jit844 DO - 10.1093/infdis/jit844 ID - Kalkowska2014 ER - TY - JOUR AU - Kalkowska, D. A. AU - Duintjer Tebbens, R. J. AU - Thompson, K. M. PY - 2014 DA - 2014// TI - Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria JO - J Infect Dis VL - 210 UR - https://doi.org/10.1093/infdis/jit834 DO - 10.1093/infdis/jit834 ID - Kalkowska2014 ER - TY - STD TI - Jafari H, Deshpande JM, Sutter RW, Bahl S, Verma H, Ahmad M, et al. Polio eradication. Efficacy of inactivated poliovirus vaccine in India. Science. 2014;345(6199):922–5. ID - ref7 ER - TY - STD TI - John J, Giri S, Karthikeyan AS, Iturriza-Gomara M, Muliyil J, Abraham A, et al. Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial. Lancet. 2014;384(9953):1505–12. ID - ref8 ER - TY - JOUR AU - Duintjer Tebbens, R. J. AU - Pallansch, M. A. AU - Kalkowska, D. A. AU - Wassilak, S. G. AU - Cochi, S. L. AU - Thompson, K. M. PY - 2013 DA - 2013// TI - Characterizing poliovirus transmission and evolution: Insights from modeling experiences with wild and vaccine-related polioviruses JO - Risk Anal VL - 23 UR - https://doi.org/10.1111/risa.12044 DO - 10.1111/risa.12044 ID - Duintjer Tebbens2013 ER - TY - STD TI - Kalkowska DA, Duintjer Tebbens RJ, Grotto I, Shulman LM, Anis E, Wassilak SGF, et al. Modeling options to manage type 1 wild poliovirus imported into Israel in 2013. J Infect Dis. 2015;211(11):1800–12. ID - ref10 ER - TY - STD TI - Grassly NC, Fraser C, Wenger J, Deshpande JM, Sutter RW, Heymann DL, et al. New strategies for the elimination of polio from India. Science. 2006;314(5802):1150–3. ID - ref11 ER - TY - STD TI - Upfill-Brown AM, Lyons HM, Pate MA, Shuaib F, Baig S, Hu H, et al. Predictive spatial risk model of poliovirus to aid prioritization and hasten eradication in Nigeria. BMC Med. 2014;12:92. ID - ref12 ER - TY - STD TI - Grassly NC, Wenger J, Durrani S, Bahl S, Deshpande JM, Sutter RW, et al. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case–control study. Lancet. 2007;369(9570):1356–62. ID - ref13 ER - TY - JOUR AU - Thompson, K. M. AU - Pallansch, M. A. AU - Duintjer Tebbens, R. J. AU - Wassilak, S. G. F. AU - Cochi, S. L. PY - 2013 DA - 2013// TI - Modeling population immunity to support efforts to end the transmission of live polioviruses JO - Risk Anal VL - 33 UR - https://doi.org/10.1111/j.1539-6924.2012.01891.x DO - 10.1111/j.1539-6924.2012.01891.x ID - Thompson2013 ER - TY - STD TI - Thompson KM, Kalkowska DA, Duintjer Tebbens RJ. Managing population immunity to reduce or eliminate the risks of circulation following the importation of live polioviruses. Vaccine. 2015;33(3):1568–77. ID - ref15 ER - TY - STD TI - Thompson KM, Kalkowska DA, Duintjer Tebbens RJ. Managing population immunity to reduce or eliminate the risks of circulation following the importation of live polioviruses. Vaccine. 2015;33(3):1568–77. ID - ref16 ER - TY - STD TI - Duintjer Tebbens RJ, Kalkowska DA, Wassilak SGF, Pallansch MA, Cochi SL, Thompson KM. The potential impact of expanding target age groups for polio immunization campaigns. BMC Infect Dis. 2014;14:45. ID - ref17 ER - TY - JOUR AU - Wagner, B. G. AU - Behrend, M. R. AU - Klein, D. J. AU - Upfill-Brown, A. M. AU - Eckhoff, P. A. AU - Hu, H. PY - 2014 DA - 2014// TI - Quantifying the impact of expanded age group campaigns for polio eradication JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0113538 DO - 10.1371/journal.pone.0113538 ID - Wagner2014 ER - TY - JOUR AU - Kalkowska, D. A. AU - Duintjer Tebbens, R. J. AU - Pallansch, M. A. AU - Cochi, S. L. AU - Wassilak, S. G. F. AU - Thompson, K. M. PY - 2015 DA - 2015// TI - Modeling undetected live poliovirus circulation after apparent interruption of transmission: Implications for surveillance and vaccination JO - BMC Infect Dis VL - 15 ID - Kalkowska2015 ER - TY - STD TI - Duintjer Tebbens RJ, Pallansch MA, Wassalik SGF, Cochi SL, Thompson KM: An economic analysis of poliovirus risk management policy options for 2013–2052. doi:10.1186/s12879-015-1112-8 BMC Inf Dis 2015 ID - ref20 ER - TY - JOUR AU - Thompson, K. M. AU - Pallansch, M. A. AU - Duintjer Tebbens, R. J. AU - Wassilak, S. G. AU - Kim, J. -. H. AU - Cochi, S. L. PY - 2013 DA - 2013// TI - Pre-eradication vaccine policy options for poliovirus infection and disease control JO - Risk Anal VL - 33 UR - https://doi.org/10.1111/risa.12019 DO - 10.1111/risa.12019 ID - Thompson2013 ER - TY - STD TI - Duintjer Tebbens RJ, Pallansch MA, Kim J-H, Burns CC, Kew OM, Oberste MS, et al. Review: Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs). Risk Anal. 2013;23(4):680–702. ID - ref22 ER - TY - BOOK PY - 2014 DA - 2014// TI - Nigeria Demographic and Health Survey 2013 PB - NPC and ICF International CY - Abuja ID - ref23 ER - TY - STD TI - World Health Organization: WHO/UNICEF estimated coverage time series. 2014. http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragepol3.html. Accessed May 29 2014. UR - http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragepol3.html ID - ref24 ER - TY - STD TI - Sutter RW, John TJ, Jain H, Agarkhedkar S, Ramanan PV, Verma H, et al. Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial. Lancet. 2010;376(9753):1682–8. ID - ref25 ER - TY - STD TI - Estívariz CF, Anand A, Gary Jr HE, Rahman M, Islam J, Bari TI, et al. Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial. Lancet Infect Dis. 2015;15(8):898–904. ID - ref26 ER - TY - STD TI - Grassly NC, Jafari H, Bahl S, Durrani S, Wenger J, Sutter RW, et al. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India. J Infect Dis. 2009;200(5):794–801. ID - ref27 ER - TY - STD TI - Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, Halsey NA, Hovi T, Minor PD, et al. Expert review on poliovirus immunity and transmission. Risk Anal. 2013;33(4):544–605. ID - ref28 ER - TY - JOUR PY - 1995 DA - 1995// TI - Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia JO - J Infect Dis VL - 171 UR - https://doi.org/10.1093/infdis/171.5.1097 DO - 10.1093/infdis/171.5.1097 ID - ref29 ER - TY - JOUR AU - Patriarca, P. A. AU - Wright, P. F. AU - John, T. J. PY - 1991 DA - 1991// TI - Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review JO - Rev Infect Dis VL - 13 UR - https://doi.org/10.1093/clinids/13.5.926 DO - 10.1093/clinids/13.5.926 ID - Patriarca1991 ER - TY - STD TI - Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, Halsey NA, Hovi T, Minor PD, et al. Review and assessment of poliovirus immunity and transmission: Synthesis of knowledge gaps and identification of research needs. Risk Anal. 2013;33(4):606–46. ID - ref31 ER - TY - JOUR AU - Mayer, B. T. AU - Eisenberg, J. N. AU - Henry, C. J. AU - Gomes, M. G. AU - Ionides, E. L. AU - Koopman, J. S. PY - 2013 DA - 2013// TI - Successes and shortcomings of polio eradication: a transmission modeling analysis JO - Am J Epidemiol VL - 177 UR - https://doi.org/10.1093/aje/kws378 DO - 10.1093/aje/kws378 ID - Mayer2013 ER - TY - JOUR AU - Hird, T. R. AU - Grassly, N. C. PY - 2012 DA - 2012// TI - Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge JO - PLoS Pathog VL - 8 UR - https://doi.org/10.1371/journal.ppat.1002599 DO - 10.1371/journal.ppat.1002599 ID - Hird2012 ER - TY - STD TI - Global Polio Eradication Initiative-circulating vaccine-derived poliovirus cases 2000–2015. 2015. http://www.polioeradication.org/Dataandmonitoring/Poliothisweek/Circulatingvaccinederivedpoliovirus.aspx. Accessed July 28 2015. UR - http://www.polioeradication.org/Dataandmonitoring/Poliothisweek/Circulatingvaccinederivedpoliovirus.aspx ID - ref34 ER -